Impact of Intracoronary Injection of Autologous BMMC for LV Contractility and Remodeling in Patients With STEMI

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

Also called NCT02323620

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02323620
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Poland (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02323620. Randomized; no masking; primary purpose treatment. Start 2019-03 (anticipated); primary completion 2022-07 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Impact of Intracoronary Injection of Autologous BMMC for LV Contractility and Remodeling in Patients With STEMI
Acronym
RACE-STEMI
Condition
Heart Failure
Intervention (Procedure)
Intracoronary infusion of BM-MC
Lead sponsor
American Heart of Poland (class: other)

Record details

Record id
cardio:ct-nct02323620
Content hash
27455158d8443e3ad1b82e7d072d7f2e3be2063687feab2b535b792f5ee0c9d5